SCHEMBL23467553

SCHEMBL23467553

CN1CCC[C@@H](C(C)(C)O)C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
CYP2D6 P10635 2/20 0.38
CYP3A4 P08684 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
PRCP P42785 6/20 0.33
CHRM3 P20309 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
TSHR P16473 1/20 0.32
CHRM2 P08172 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA2A P08913 1/20 0.32
CHRM1 P11229 1/20 0.32
DRD1 P21728 1/20 0.32
TBXA2R P21731 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13881895 1.00 ATM (0.54) ATML3MBTL1CYP2D6CYP3A4SMN1; SMN2
SCHEMBL23425965 1.00 ATM (0.54) ATML3MBTL1CYP2D6CYP3A4SMN1; SMN2
SCHEMBL13713126 0.86 ATM (0.41) ATML3MBTL1ALDH1A1CYP1A2CHRM3
SCHEMBL2612760 0.82 ATM (0.49) ATML3MBTL1CYP2D6CYP3A4SMN1; SMN2
SCHEMBL6784593 0.82 ATM (0.49) ATML3MBTL1CYP2D6CYP3A4SMN1; SMN2
SCHEMBL18923903 0.82 ATM (0.49) ATML3MBTL1CYP2D6CYP3A4SMN1; SMN2
SCHEMBL12928730 0.76 L3MBTL1 (0.45) ATML3MBTL1CYP2D6CYP3A4SMN1; SMN2
SCHEMBL1047497 0.76 L3MBTL1 (0.49) ATML3MBTL1CYP2D6CYP3A4SMN1; SMN2
SCHEMBL12928749 0.76 L3MBTL1 (0.45) ATML3MBTL1CYP2D6CYP3A4SMN1; SMN2
SCHEMBL12928741 0.76 L3MBTL1 (0.45) ATML3MBTL1CYP2D6CYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11028085-B2 Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists Nimbus Saturn, Inc. (US) 2021-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11028085-B2 Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists HIPK1, PDXK, IP6K1 ATM 1455/4885L3MBTL1 2183/4885CYP2D6 2694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.